Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2012 Oct;60(4):408–416. doi: 10.1097/FJC.0b013e318247f642

Table 2.

Advantages and disadvantages of different modeling approaches.

Disease model Advantage Disadvantage
Animal (mouse, rat)
  • In-vivo context of whole organism

  • Relatively standardized protocols

  • No comprehensive reflection of human disease

  • No animal models for some diseases

  • Laborious and costly maintenance

  • Ethical concerns

Classical tissue culture
  • Stable, standardized and reproducible

  • Economical

  • High-throughput assays possible

  • Ethically unbiased

  • No comprehensive reflection of organism/systems biology

  • No comprehensive disease modeling

hESCs
  • Realistic model of human disease

  • Patients-specific cells possible via therapeutic cloning

  • Ethical concerns

  • Limited availability of human oocytes

  • Partially immature phenotype

iPSCs
  • Realistic model of human disease

  • Patient-specific cells

  • Pluripotent and unlimited supply

  • Ethically unbiased

  • Partially immature phenotype

  • Uncontrolled viral integration into genome during iPSC derivation poses limitations for comprehensive conclusions, non-viral derivation methods required

Adult stem cells
  • Realistic model of human disease

  • Patient-specific cells

  • Ethically unbiased

  • Partially immature phenotype

  • Supply very limited

  • Isolation and expansion in culture very difficult

  • Capacity of unlimited self-renewal and plasticity unclear